首页|期刊导航|肿瘤学创新(英文)|Diagnostic Value of PET/CT for Ovarian Cancer Recurrence or Metastasis in Postoperative Patients With Elevated Serum CA125 Levels:A Systematic Review and Meta-Analysis

Diagnostic Value of PET/CT for Ovarian Cancer Recurrence or Metastasis in Postoperative Patients With Elevated Serum CA125 Levels:A Systematic Review and Meta-AnalysisOA

Diagnostic Value of PET/CT for Ovarian Cancer Recurrence or Metastasis in Postoperative Patients With Elevated Serum CA125 Levels:A Systematic Review and Meta-Analysis

Zuowei Zou;Luhua Xia;Saikang Tang;Lin Lin;Quanyang Wu;Donghui Hou;Shijun Zhao

Department of Nuclear Medicine,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Nuclear Medicine,Tumor Hospital Affiliated to Xinjiang Medical University,Urumqi,Xinjiang,ChinaDepartment of Diagnostic Radiology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Nuclear Medicine,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Diagnostic Radiology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Diagnostic Radiology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Diagnostic Radiology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China

carbohydrate antigen 125diagnostic accuracymetastasisovarian cancerPET/CTrecurrence

carbohydrate antigen 125diagnostic accuracymetastasisovarian cancerPET/CTrecurrence

《肿瘤学创新(英文)》 2025 (4)

36-45,10

This study was supported by Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences(grant no.2021-I2M-C&T-B-063),Collaborative Education Program between the Ministry of Education and Industry of China(grant no.230805236315631),and National Key Research and Development Program of China(grant no.2020AAA0109500).

10.1002/cai2.70015

评论